- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01217996
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Participants randomized to the intervention arm will complete the computerized working memory training program. This computer-based training program is completed in the home and requires approximately 30 minutes every weekday for five weeks. The program software guides the child through eight rotating exercises each day, with increasing difficulty based on the child's level of performance. Exercises train both visuospatial and verbal WM using child-friendly activities. A research team member will serve as a coach who monitors weekly progress online and offers support through weekly phone calls with the study participants and their caregivers. This individual will not complete post-intervention assessments to maintain study blind. A home computer with internet connection and speakers is required. A laptop computer and/or wireless internet access will be provided to families whose only obstacle to participation is lack of computer access or internet connectivity in the home setting. Families randomized to the WM intervention will complete a tutorial with study staff that provides instruction in using a computer, the internet and the WM training software.
The objective of this study is to investigate the benefits of this working memory intervention in a sample of childhood cancer survivors and look at brain-based changes that may occur as the result of working memory intervention. To achieve this goal, we plan to study childhood cancer survivors randomly assigned to the working memory intervention or a passive waitlist. Both groups will participate in cognitive testing pre-, post-, and six months post intervention. Intervention participants will also partake in neuroimaging exams before and after the intervention. Findings from this study have direct potential to support a nonpharmaceutical cognitive intervention for cancer survivors that is a safe and effective alternative to stimulant medications with great promise for improving quality of life.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Tennessee
-
Memphis, Tennessee, Verenigde Staten, 38105
- St. Jude Children's Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria for Screening Phase:
- Received CNS-directed treatment (intrathecal chemotherapy or cranial irradiation) for a BT or ALL
- Infratentorial tumor location (for the BT cohort)
- Off treatment for at least one year with no evidence of recurrent or progressive disease
- Age 8-16 years inclusive at the time of enrollment
- English as the primary language
- Research participant and one parent willing to participate and provide consent/assent according to institutional guidelines
Exclusion Criteria for Screening Phase
- Significant impairment in global intellectual functioning (estimated or full scale IQ < 70 based on standardized testing routinely conducted on primary treatment protocols)
- History of CNS injury/disease predating or unrelated to cancer diagnosis
- Documented ADHD predating cancer diagnosis
- Treatment with psychostimulant or psychotropic medication within two weeks of study participation
- Major sensory or motor impairment that would preclude valid cognitive testing secondary to inability to complete study procedures (e.g., blindness, paresis, poorly controlled seizures/photosensitive epilepsy, psychosis)
Inclusion Criteria for Intervention Phase
- Signed screening consents and has undergone screening
- Fully evaluable psychological testing results (including IQ > or = 70)
- Age-scaled score on Digit Span, Letter-Number Sequencing or Spatial Span < 7 OR at least one standard deviation below IQ score
- Training aide is available to participate in required sessions
- Participant and training aide demonstrate computer proficiency
- Participant has access to or will be provided a laptop or home computer with internet connection and speakers
- Participant willing to participate in required aspects of computerized intervention
- Participant is able to take part in fMRI without sedation
Exclusion Criteria for Intervention Phase
- Major psychological condition that would preclude completion of protocol intervention (e.g., significant oppositionality, autism spectrum disorder, severe anxiety or depressive symptoms)
- Orthodontic appliances that cause MRI distortion or signal loss outside the mouth and sinus area
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: Intervention Group
Children treated for a brain tumor (BT) or acute lymphoblastic leukemia (ALL) will complete the computerized working memory training program (intervention).
|
A computer-based training program will be completed in the home.
This program requires approximately 30 minutes every weekday for five weeks.
The program software guides the child through eight rotating exercises each day, with increasing difficulty based on the child's level of performance.
Exercises train both visuospatial and verbal WM using child-friendly activities.
A research team member will serve as a coach who monitors weekly progress online and offers support through weekly phone calls with the study participants and their caregivers).
Intervention participants will also partake in neuroimaging exams before and after the intervention
|
|
Ander: Control Group
Children treated for a brain tumor (BT) or acute lymphoblastic leukemia (ALL) will complete the computerized working memory training program (control).
|
Participants randomized to the control group will not complete any intervention during the intervention time period and will not partake in neuroimaging exams.
They will complete an immediate and six month post follow-up cognitive assessment.
Following completion of these assessments, they will be provided the opportunity to complete the computer-based training program off study.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
This study will measure working memory, attention and executive functions
Tijdsspanne: Baseline, 10 weeks, and 6 months
|
Participants in the working memory intervention will demonstrate significantly greater improvement from pre- to immediate post-intervention on performance- and rater-based measures of working memory relative to childhood cancer survivors placed on an intervention waitlist.
|
Baseline, 10 weeks, and 6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
The study will measure the maintenance of improvements on measures of working memory, attention and executive functions
Tijdsspanne: 6 months.
|
The improvements will be evaluated at six months following participation in the computer-based intervention program.
|
6 months.
|
|
This study will examine the neural correlates of working memory before and immediately after intervention
Tijdsspanne: Baseline and 10 weeks.
|
This objective will use fMRI to examine the neural correlates of working memory before and immediately after intervention.
|
Baseline and 10 weeks.
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Heather M Conklin, Ph.D, St. Jude Children's Research Hospital
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- COGTRN
- 120421-RSGPB-11-009-01-CPPB (Ander subsidie-/financieringsnummer: American Cancer Society)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .